Pharma's Market
SPECIAL REPORT
MOST SHARED
- Criminal Probe Trail Going Cold at MF Global
- Global Markets Update: Markets Soften After Failure to Clinch Greek Deal
- Israel Likely to Bomb Iran This Year: Political Analyst
- Bank of America’s Worst-Case Scenario Gets More Real
- EU Agrees Rules for $700 Trillion Derivatives Market
- Stocks Seen Lower; Greek Debt Hurdles Remain
- CPAC 2012: Energized or Demoralized?
- Greek Aid Deal 'Much Better' Than Euro Exit: Summers
- Global Markets Update: European Markets Follow Asia Lower
- Greeks on Strike as the Second Bailout Is in Limbo
- Bank of America’s Worst-Case Scenario Gets More Real
- Tesla Unveils First SUV: Model X
- New York Fashion Week Hits the Runway as Colors Pop
- Mulling Buffett's Stock Advice? Get in With REITs: Fund Managers
- LinkedIn Earnings Bode Well for Hiring and Social Media
- Top Five Mistakes to Avoid in Online Dating
- Victor Cruz ‘Understands’ Gisele's Super Bowl Frustrations
- Tamminen: The United States of India
- Unusual Volume: Taleo Jumps After Oracle's $1.9 Billion Offer
- Bonus Bloodbath: Europe Banker Backlash Continues
- US Trade Deficit Swells to $48.8 Billion on China Gap
- Stocks Looking Past Europe for a New Driver of the Rally
- SEC Reaches Settlement in Bear Stearns Fraud Case
- Israel Likely to Bomb Iran This Year: Political Analyst
- EU Agrees Rules for $700 Trillion Derivatives Market
- The World's Best Beers
- Rep. Bachus Faces Insider Trading Probe: Report
- In Europe, Stagnation as a Way of Life
RSS FEED
Drug Sales Reps And Doctors: The Real "Pharma's Market"
Reporter
![]() |
CNBC.com |
Who hasn't seen at least one drug salesperson sitting in the waiting room of their doctor's office? This piece aims to clue people in about how the reps do their jobs and influence the physicians to send you home with a prescription for a particular medication.
And it's not just about free pens, pads of paper and dinners at Ruth's Chris Steakhouse. At the risk of sounding like a local TV-news promotional cliche, I think some of the anecdotes and sales tactics will surprise you.
For example, there's a former sales rep who says he and his colleagues used to refer to doctors as "drug whores". That same former rep says one of the doctors he'd call on could be persuaded to write prescriptions for certain drugs depending on which company's sales rep got him sporting event tickets. And on the flip side, a doctor whose practice turned down an estimated half-a-million dollars in annual "rebates" from a major biotech company.
Many of the major drug companies are laying off thousands of sales reps. In the face of declining sales, generic competition, drug development pipeline and commercial disappointments the firms have to cut costs. Analysts have been saying for quite some time that there are way too many sales reps calling on doctors. But tens of thousands of them who are still on the payroll are encountering a growing level of pushback from busy docs and frustrated, prominent med school.
At my suggestion, CNBC bought an ad for the story on www.cafepharma.com to promote it and hopefully generate buzz. The site is primarily geared toward pharma and biotech employees, especially sales reps who are looking for jobs, company insight, to chat and, frankly, spread gossip and rumors. There are already at least a couple of threads that have apparently grown out of the ad which will be on the site for about a week.
I hope it promotes intelligent debate and the show--9p and midnight ET this Wednesday--and that you'll watch.
Questions? Comments?









